NUS Links:
This study reports a novel inhibitor oxide (MPO) which promotes inhibition of growth in pancreatic and hepatocellular cancer cell lines by inducing cell cycle arrest. Hence authors in this study led by Prof Shazib Pervaiz provide proof-of-concept for therapeutic potential of this novel inhibitor against cancers.
Link to website: https://bit.ly/3HQnIsb
CIITA is the master regulator of MHC class-II immune genes that are important for defense mechanism against infections and cancer …
Chemotherapy, although the first line of defense in cancer treatment, is indiscriminate and is damaging to the entire body, which, …
This research, led by N2CR members Prof Goh Boon Cher and Prof Shazib Pervaiz with Dr Jayshree Hirpara as the …